- Home
- CUK vs BNTX Comparison
CUK vs BNTX Comparison
Compare CUK & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CUK | BNTX |
|---|---|---|
| Founded | 1972 | 2008 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.2B | 24.8B |
| IPO Year | 2000 | 2019 |
Fundamental Metrics
Financial Performance| Metric | CUK | BNTX |
|---|---|---|
| Price | $31.10 | $92.51 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 18 | 11 |
| Target Price | $35.06 | ★ $137.40 |
| AVG Volume (30 Days) | ★ 2.4M | 1.5M |
| Earning Date | 12-19-2025 | 11-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 40.51 | N/A |
| EPS | ★ 2.02 | N/A |
| Revenue | ★ $26,622,000,000.00 | $3,698,814,972.00 |
| Revenue This Year | $6.91 | $2.36 |
| Revenue Next Year | $3.94 | N/A |
| P/E Ratio | $14.79 | ★ N/A |
| Revenue Growth | ★ 6.40 | 3.70 |
| 52 Week Low | $13.65 | $81.20 |
| 52 Week High | $31.24 | $129.27 |
Technical Indicators
Market Signals| Indicator | CUK | BNTX |
|---|---|---|
| Relative Strength Index (RSI) | 79.66 | 35.58 |
| Support Level | $25.97 | $91.11 |
| Resistance Level | $26.79 | $93.76 |
| Average True Range (ATR) | 0.91 | 2.08 |
| MACD | 0.62 | -0.33 |
| Stochastic Oscillator | 97.59 | 15.27 |
Price Performance
Historical ComparisonAbout CUK Carnival Plc ADS ADS
Carnival is the largest global cruise company, with more than 90 ships in service. Its portfolio of brands includes Carnival Cruise Lines, Holland America, Princess Cruises, and Seabourn in North America; P&O Cruises and Cunard Line in the United Kingdom; Aida in Germany; Costa Cruises in Southern Europe. It recently folded its P&O Australia brand into Carnival. The firm also owns Holland America Princess Alaska Tours in Alaska and the Canadian Yukon. Carnival's brands attracted 14 million guests in 2024.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.